Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scrip Team

Set Alert for Articles By Scrip Team

Latest From Scrip Team

Publisher's Spotlight: The 2019 Scrip Awards Is Now Open For Nominations

Come and celebrate your vital contribution to improving human health worldwide – the 2019 Scrip Awards is now open for entries.

Commercial BioPharmaceutical

Executives On The Move: Biology Leader Exits Gilead, And Promotions At Mitsubishi And Sanofi

Exiting Gilead biology leader lands CSO post at blood cancer company Amphivena Therapeutics. Sanofi moves its Brazil general manager to head China Emerging Markets Business Unit and Mitsubishi Tanabe Pharma America promotes area director to VP, ops and strategy.

Appointments BioPharmaceutical

Executives On The Move: Bio/Med Changes Made From Lilly And Amgen, And A Step Up R&D Ladder At Daiichi Sankyo

Eli Lilly & Co’s Biology VP takes on SVP, Discovery role at gene regulatory mechanism firm Fulcrum Therapeutics, and Amgen Med Affairs exec becomes CMO at Matinas BioPharma Holdings. At Daiichi Sankyo, R&D leader steps up to Global Head, R&D position.

Appointments BioPharmaceutical

Executives On The Move: CEOs Welcomed At Cadent Therapeutics And Enzyvant Sciences, And Top Development Spot Filled At Bicycle Therapeutics

A new CEO for movement and cognitive disorder company Cadent Therapeutics, and Alexion SVP departs for CEO position at rare disease therapy firm Enzyvant Sciences. Plus transatlantic biotech Bicycle Therapeutics appoints a CBO, while Simon Moroney announces his departure from MorphoSys.

Appointments BioPharmaceutical

Executives On The Move: New Responsibilities For Sanofi CMO, A Strategic Promotion At Alexion And A C-Level Resignation At Medivir

To integrate digital and medical, Sanofi’s CMO Ameet Nathwani is now also Chief Digital Officer. Alexion promotes SVP to Chief Strategy and Business Development Officer, and the CFO resigns from Swedish oncology biotech Medivir.

Appointments BioPharmaceutical

Executives On The Move: C-Suite Exits At Pfizer, Celgene And Sandoz, New President At MorphoSys

C-suite moves at cancer biotech Geron Corp, EMD Serono Inc and Kiadis Pharma, while German biotech MorphoSys AG names David Trexler as its new president.

BioPharmaceutical Appointments
See All